The number# 1 thing to look for in arthritis trials is if the secondary endpoint was met - that means it shows statistically significant difference over the placebo. According to my Rheumotologist did not meet the goal, but that was from an earlier trial. I would like to see if they did. Sadly, it's missing here.
Cosentyx doing well for psoriatic arthritis 1 year on
|
« Next Oldest | Next Newest »
|
Messages In This Thread |
Cosentyx doing well for psoriatic arthritis 1 year on - by Fred - Mon-29-06-2015, 10:53 AM
RE: Cosentyx doing well for psoriatic arthritis 1 year on - by jiml - Mon-29-06-2015, 11:31 AM
RE: Cosentyx doing well for psoriatic arthritis 1 year on - by Caroline - Tue-30-06-2015, 12:46 PM
RE: Cosentyx doing well for psoriatic arthritis 1 year on - by jiml - Tue-30-06-2015, 20:09 PM
RE: Cosentyx doing well for psoriatic arthritis 1 year on - by mataribot - Mon-29-06-2015, 19:48 PM
|
Possibly Related Threads… | |||||
Thread | Author | Replies | Views | Last Post | |
Bimzelx vs Skyrizi study for psoriatic arthritis | Fred | 0 | 513 |
Mon-30-09-2024, 14:22 PM Last Post: Fred |
|
Taltz 5 year study | Fred | 13 | 5,961 |
Tue-06-02-2024, 12:28 PM Last Post: Kat |
|
Polymorphisms associated with Cosentyx | Fred | 6 | 2,965 |
Sun-07-01-2024, 11:01 AM Last Post: Caroline |
|
Bimzelx gets recommendation for psoriatic arthritis in the EU | Fred | 2 | 2,657 |
Sat-10-06-2023, 14:33 PM Last Post: Forest Walker |
|
Tremfya for psoriatic arthritis phase 3b data | Fred | 0 | 1,486 |
Wed-31-05-2023, 16:26 PM Last Post: Fred |
Users browsing this thread: 2 Guest(s)